ReviewThe journal of headache and pain2025
Is canonical SD a clinically relevant model of migraine? Argument con.
Review in The journal of headache and pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- BOLD repetition enhancement in the orbitofrontal cortex during complex visuospatial processing in migraine without aura: a shift in periaqueductal gray - cortical coupling?The journal of headache and pain · 2026Article
- Is canonical SD a clinically relevant model of migraine? Argument pro.The journal of headache and pain · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cortical spreading depolarization (CSD) is a unique brain response to a neuronal insult, manifested by a massive exchange of intra- and extracellular compartments, loss of ionic gradients, and membrane potential, where neurons are caged in this pathological state for minutes with no activity. This electrochemical tsunami propagates slowly by invading the neighboring intact cortex in the whole hemisphere in rodents, and it is transient in metabolically uncompromised brains. Vascular reactivity of brief hyperemia, prolonged oligemia, increased inhibitory synaptic tonus, intracellular edema, and blood-brain barrier disruption are the typical features of canonical CSD. The translation of canonical CSD to migraine aura symptoms in humans presents significant inconsistencies. These include positive symptomatology of aura and the temporal discrepancy between the multisensory manifestation of aura and allegedly affected cortical areas, the limited march of CSD in the intact human brain, laterality of aura and headache, and the lack of CSD-inducing capability of migraine-triggering substances. No study showed direct evidence of canonical CSD during migraine aura. Reported findings depend on vascular reactivity changes that are spatially and temporally discordant with clinical symptoms. Given these limitations, canonical CSD, as the underlying cause of migraine aura and headache, oversimplifies a more complex system and raises doubts about its sufficiency as a sole explanatory model and as a therapeutic target. We argue that while CSD may play a role in migraine pathophysiology, it is unlikely to propagate in the same manner as the canonical CSD observed in rodents. CSD in higher-order cortical areas may disrupt the cortico-thalamo-cortical loop in the sensory or pain network. This perspective better accommodates the complex sensory phenomena observed in migraine aura and may lead to more effective and targeted patient treatments by broadening the conceptual framework of migraine pathophysiology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.